Jazz Pharmaceuticals plc (JAZZ) Total liabilities 2016–2025
Jazz Pharmaceuticals plc (JAZZ) total liabilities at each fiscal year-end, per SEC filings.
$7.3BFY2025 · since FY2016: $2.9B → $7.3B
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | $7.3B | -7.3% |
| FY2024 | $7.9B | +3.4% |
| FY2023 | $7.7B | -1.2% |
| FY2022 | $7.7B | -7.0% |
| FY2021 | $8.3B | +189.7% |
| FY2020 | $2.9B | +18.5% |
| FY2019 | $2.4B | -0.7% |
| FY2018 | $2.4B | +1.5% |
| FY2017 | $2.4B | -17.5% |
| FY2016 | $2.9B | — |
Years the filer does not tag total liabilities directly are shown as reported total assets − reported shareholders’ equity at the same fiscal year-end.
Source: SEC XBRL filings · For reference only · Not investment advice